Anticholinergic Burden in Older Adults: How Common Medications Affect Memory and Thinking

Many older adults take medications every day to manage pain, allergies, bladder issues, or depression. But what if some of those pills are quietly harming their memory and thinking? That’s the reality of anticholinergic burden - a hidden risk built into common prescriptions and even over-the-counter drugs. It’s not a disease. It’s not a rare side effect. It’s the slow, cumulative damage caused by drugs that block a key brain chemical called acetylcholine. And for seniors, that damage can show up as confusion, forgetfulness, or even faster progression toward dementia.

What Exactly Is Anticholinergic Burden?

Anticholinergic burden, or ACB, is the total amount of anticholinergic drugs a person is taking. These drugs stop acetylcholine from doing its job - sending signals between nerve cells. In the brain, acetylcholine helps with attention, memory, and learning. When it’s blocked, those functions slow down. It’s like turning down the volume on your brain’s most important conversations.

The problem isn’t one drug. It’s the sum of many. A person might take diphenhydramine (Benadryl) for sleep, oxybutynin for an overactive bladder, and amitriptyline for nerve pain. Each one carries a small risk. Together, they add up. That’s why doctors now use scoring systems like the ACB scale to measure the total burden. Each drug gets a rating: Level 1 (mild), Level 2 (moderate), or Level 3 (strong). A score of 3 or higher is considered high risk. A score of 6 or more? That’s a red flag.

Which Medications Carry the Highest Risk?

Not all anticholinergics are the same. Some cross into the brain easily. Others stay mostly in the body. The worst offenders are the ones that reach the brain and stay there.

• First-generation antihistamines: Diphenhydramine (Benadryl), chlorpheniramine. These are in many sleep aids and cold medicines. They’re cheap, easy to get, and dangerously common.
• Overactive bladder drugs: Oxybutynin, tolterodine. These help with frequent urination, but they also fog the mind. Many seniors don’t realize their confusion isn’t just aging - it’s the medication.
• Tricyclic antidepressants: Amitriptyline, nortriptyline. These are older antidepressants. Newer ones like sertraline or escitalopram don’t have this effect.
• Antipsychotics: Chlorpromazine, quetiapine. Used for behavioral issues in dementia, but they worsen cognition.
• Pain meds: Some muscle relaxants like cyclobenzaprine.

In 2022, about 10% of adults over 65 in the U.S. were taking drugs with strong anticholinergic effects. That’s over 5 million people. And in many cases, these drugs were prescribed without anyone ever mentioning the brain risks.

How Do These Drugs Actually Damage the Brain?

It’s not just about feeling foggy. Brain scans show real, measurable changes.

A 2016 study in JAMA Neurology found that older adults taking even moderate levels of anticholinergic drugs had 4% less glucose use in the temporal lobe - the same area that shuts down early in Alzheimer’s disease. Less glucose means less energy for brain cells to work properly.

MRI scans from the Indiana Memory and Aging Study showed that people on high ACB medications lost brain volume 0.24% faster each year than those not taking them. That’s not just aging. That’s accelerated shrinkage.

And it’s not random. The brain regions hit hardest are the hippocampus (memory) and the prefrontal cortex (planning, focus). That’s why the biggest declines show up in two areas: episodic memory (forgetting names, appointments, recent conversations) and executive function (trouble making decisions, following instructions, switching tasks).

In the ASPREE study of nearly 20,000 seniors, each extra point on the ACB scale meant a 0.15-point greater yearly drop on tests of word fluency. That might sound small, but over three years, it adds up to a noticeable decline in daily function.

How Long Does It Take to See the Damage?

It’s not overnight. But the longer you take these drugs, the worse it gets.

A landmark 2015 study found that people who took anticholinergic drugs for three years or more had a 54% higher risk of developing dementia than those who took them for less than three months. The risk climbed steadily with each year of use. Even people who never had memory problems before started showing signs.

And here’s the scary part: the damage doesn’t always reverse right away. In the DICE trial, seniors who stopped high-risk medications took 4 to 8 weeks just to start feeling clearer. Full cognitive recovery took 12 weeks or more. Some never fully bounced back.

What Do Experts Say?

The American Geriatrics Society’s 2023 Beers Criteria says: avoid strong anticholinergics in older adults. Period. The European Medicines Agency banned dimenhydrinate in dementia patients in 2020. The FDA now requires stronger warning labels on all these drugs.

Dr. Malaz Boustani, who helped create the ACB scale, calls this one of the few modifiable risk factors for dementia we actually have control over. That’s huge. We can’t stop aging. But we can stop taking drugs that make brain decline worse.

But not everyone agrees. Some doctors point out that people prescribed these drugs often have other health problems - depression, chronic pain, bladder issues - that might themselves raise dementia risk. That’s true. But even after adjusting for those factors, the link between anticholinergic burden and cognitive decline still shows up in study after study.

Real People, Real Stories

On forums like AgingCare.com, caregivers are sharing what happens when these drugs are stopped.

One woman wrote: “My mom was confused all the time. She forgot where she was, who we were. We thought it was dementia. Then her doctor switched her from oxybutynin to a different bladder med. Two weeks later, she remembered her grandchildren’s names. She started laughing again.”

The FDA recorded over 1,200 cognitive-related adverse events in seniors between 2018 and 2022. The most common? Confusion, memory loss, and sudden delirium. In a 2021 survey, 63% of older adults said they were never told about these risks when the drugs were prescribed. And 41% said they’d have chosen something else if they’d known.

What Can Be Done?

The good news? You can do something about this.

• Ask for a med review. Bring every pill, capsule, and patch you take - including OTC ones - to your doctor or pharmacist. Ask: “Do any of these have anticholinergic effects?”
• Ask for alternatives. For allergies? Try loratadine or cetirizine - they don’t cross into the brain. For overactive bladder? Mirabegron is a good option. For depression? SSRIs like sertraline have almost no anticholinergic effect.
• Don’t stop cold turkey. Some meds, like antidepressants, need to be tapered slowly. Work with your doctor.
• Use the ACB Calculator. The American Geriatrics Society launched a free app in 2024. Just type in your meds. It gives you a score and tells you which ones are risky.

Doctors need more time for this. A 2021 survey found it takes an average of 23 minutes per patient to do a full med review. But most appointments are 10 to 15 minutes. That’s why many seniors slip through the cracks.

What’s Next?

The National Institute on Aging is funding a major new study called CHIME, which will follow 3,500 older adults over four years. Half will get help reducing anticholinergic drugs. The other half won’t. The goal? Prove that lowering ACB can actually delay or prevent dementia.

Right now, experts believe anticholinergic burden contributes to 10-15% of dementia cases in older adults. That’s tens of thousands of cases every year - cases that could have been avoided.

This isn’t about scaring people away from medicine. It’s about using the right medicine. For every drug that harms the brain, there’s usually a safer alternative. The question isn’t whether you need treatment. It’s whether you need this treatment.

Frequently Asked Questions